Side-Effects of Anti-Inflammatory Therapy in Uveitis. (September 2014)

• Record Type: Journal Article
• Authors: Uchiyama, Eduardo; Papaliodis, George N.; Lobo, Ann-Marie; Sobrin, Lucia
• Is Part Of: Seminars in ophthalmology. Volume 29:Number 5/6(2014)
• Page Start: 456
• Page End: 467
• Publication Date: 2014-09
• Subjects: Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; Eye -- Surgery -- Periodicals; 617.7005
• DOI: 10.3109/08820538.2014.959203
• Languages: English
• ISSNs: 0882-0538

Abstract

<abstract> <title>Abstract</title> <p>Uveitis is a group of inflammatory ocular conditions that cause significant visual morbidity around the world. Many of the cases of blindness secondary to uveitis can be avoided with adequate and aggressive management of the intraocular inflammation. Steroids have been utilized in the treatment of noninfectious uveitis for more than 60 years, but their chronic use is associated with severe ocular and systemic side-effects. Ophthalmologists are often not familiar with the systemic steroid-sparing agents available for the management of ocular inflammation and depend primarily on the use of corticosteroids. In this article, we review the most common agents utilized in the treatment of uveitis and their side-effect profiles.</p> </abstract>